California information swimsuit in opposition to PBMs over insulin costs
Dive Temporary:
- California is suing main drug producers and pharmacy advantages managers for allegedly leveraging their marketplace energy to overcharge sufferers for insulin, consistent with a unlock from California Legal professional Basic Rob Bonta.
- The state filed swimsuit Thursday in opposition to drug producers Eli Lilly, Novo Nordisk, and Sanofi, along side main PBMs CVS Caremark, Cigna’s Categorical Scripts and UnitedHealth Team’s OptumRx.
- The lawsuit alleges that the drugmakers and PBMs labored in combination to pressure up the cost of insulin thru unlawful and misleading trade practices in violation of California’s Unfair Pageant Regulation.
Dive Perception:
Insulin generally